These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 30119248)
1. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo. Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248 [TBL] [Abstract][Full Text] [Related]
2. Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis. Matsuyama W; Watanabe M; Shirahama Y; Mitsuyama H; Higashimoto I; Osame M; Arimura K Am J Pathol; 2006 Mar; 168(3):866-77. PubMed ID: 16507902 [TBL] [Abstract][Full Text] [Related]
3. Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis. Matsuyama W; Watanabe M; Shirahama Y; Oonakahara K; Higashimoto I; Yoshimura T; Osame M; Arimura K J Immunol; 2005 May; 174(10):6490-8. PubMed ID: 15879152 [TBL] [Abstract][Full Text] [Related]
4. Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation. Matsuyama W; Watanabe M; Shirahama Y; Hirano R; Mitsuyama H; Higashimoto I; Osame M; Arimura K J Immunol; 2006 Feb; 176(3):1928-36. PubMed ID: 16424224 [TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of ginsan on TGF-β mediated fibrotic process. Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375 [TBL] [Abstract][Full Text] [Related]
6. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis]. Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. Wang XM; Zhang Y; Kim HP; Zhou Z; Feghali-Bostwick CA; Liu F; Ifedigbo E; Xu X; Oury TD; Kaminski N; Choi AM J Exp Med; 2006 Dec; 203(13):2895-906. PubMed ID: 17178917 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening. Chen C; Deng J; Yu X; Wu F; Men K; Yang Q; Zhu Y; Liu X; Jiang Q Mol Biosyst; 2016 Apr; 12(5):1540-51. PubMed ID: 26956955 [TBL] [Abstract][Full Text] [Related]
10. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats. Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887 [TBL] [Abstract][Full Text] [Related]
11. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Avivi-Green C; Singal M; Vogel WF Am J Respir Crit Care Med; 2006 Aug; 174(4):420-7. PubMed ID: 16690978 [TBL] [Abstract][Full Text] [Related]
12. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo. Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129 [TBL] [Abstract][Full Text] [Related]
13. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis. Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610 [TBL] [Abstract][Full Text] [Related]
14. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation. Kim S; Lim JH; Woo CH Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924 [TBL] [Abstract][Full Text] [Related]
15. Tuberostemonine may alleviates proliferation of lung fibroblasts caused by pulmonary fibrosis. Tang A; Liu Y; Ding Q; Huang G; Sha Z; Yang C; Cao F Int J Immunopathol Pharmacol; 2024; 38():3946320241274225. PubMed ID: 39140804 [TBL] [Abstract][Full Text] [Related]
16. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300. Williams LM; McCann FE; Cabrita MA; Layton T; Cribbs A; Knezevic B; Fang H; Knight J; Zhang M; Fischer R; Bonham S; Steenbeek LM; Yang N; Sood M; Bainbridge C; Warwick D; Harry L; Davidson D; Xie W; Sundstrӧm M; Feldmann M; Nanchahal J Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20753-20763. PubMed ID: 32759223 [TBL] [Abstract][Full Text] [Related]
17. Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis. Liu F; Yu F; Lu YZ; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Song LJ; He XL; Xiong L; Xin JB; Ma WL; Ye H Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118806. PubMed ID: 32739525 [TBL] [Abstract][Full Text] [Related]
18. Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis. Shoda H; Yokoyama A; Nishino R; Nakashima T; Ishikawa N; Haruta Y; Hattori N; Naka T; Kohno N Biochem Biophys Res Commun; 2007 Feb; 353(4):1004-10. PubMed ID: 17198680 [TBL] [Abstract][Full Text] [Related]
19. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis. Xie H; Lu J; Zhu Y; Meng X; Wang R Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the K Organ L; Bacci B; Koumoundouros E; Kimpton WG; Samuel CS; Nowell CJ; Bradding P; Roach KM; Westall G; Jaffar J; Snibson KJ Am J Respir Cell Mol Biol; 2017 Apr; 56(4):539-550. PubMed ID: 28060543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]